Komodo Health Launches New AI Tools for Better Insights
Komodo Health, a leader in healthcare technology, is thrilled to introduce two innovative products within its MapLab platform. These new tools aim to make access to the industry's largest collection of de-identified patient-level insights much simpler. With the launch of MapAI™ and MapExplorer™, Komodo is taking a significant step towards enhancing the workflow for insights. These powerful AI tools enable the generation of relevant, accurate, and context-aware insights and analyses at a much faster pace. Both products belong to MapLab, the industry’s comprehensive suite designed to democratize and facilitate insight generation for healthcare and Life Sciences organizations.
Enhancing Workflows with Generative AI
MapAI serves as Komodo’s innovative AI analytics assistant, designed to improve collaboration among multiple users in healthcare and Life Sciences analyses. Utilizing sophisticated natural language processing, MapAI offers an intuitive approach to analyzing data using Komodo’s Healthcare Map™—the most extensive source for real-world data available. This helps companies understand trends in patient care, disease epidemiology, and provider relationships. With this advancement, decision-making is sped up: users at any skill level can pose complex analytic questions in simple language and receive clear answers in minutes rather than the usual hours or days.
Ensuring Data Integrity and Privacy
Built using leading open-source large language model frameworks, MapAI delivers straightforward and digestible insights while maintaining strict adherence to data integrity and privacy regulations. This generative AI solution enables users to explore, validate, and refine their hypotheses quickly before delving deeper into analyses. This promotes collaboration across various teams, bridging the gap between technical and non-technical users. Consequently, organizations can make faster, data-driven decisions through a unified intelligence platform.
Insights Integrated into MapView
The insights produced by MapAI can be easily transferred into MapView™, Komodo's no-code platform that comes equipped with pre-configured analytical modules for tasks such as disease and market analysis, patient and healthcare provider segmentation, and assessing brand performance. This functionality allows users to generate insightful reports quickly, vastly improving efficiency.
Quick Insights Across Various Disease Areas
Another exciting addition to the MapLab suite is MapExplorer, designed to provide users with swift, high-level insights across patient populations, providers, and payers through a user-friendly no-code interface. MapExplorer is a robust tool tailored for companies that are new to the Healthcare Map, granting access to extraordinary insights and analytical capabilities. Thanks to its intuitive point-and-click functionality and conversational AI features, teams can seamlessly explore Komodo’s extensive real-world insights spanning diverse therapeutic areas.
Supporting Life Sciences Organizations
MapExplorer is aimed at empowering Life Sciences organizations of all sizes by democratizing access to real-time insights. This tool enables users to examine diverse patient demographics and treatment pathways before committing to in-depth analysis.
“With the launch of MapAI and MapExplorer, we're reshaping the healthcare analytics landscape by simplifying the transition from data gathering to actionable decision-making,” said Laurent Bride, Chief Technology Officer at Komodo Health. “These generative AI features within our MapLab platform empower users to ask questions in plain language and instantly receive impactful insights, effectively breaking down barriers to data-driven intelligence and enabling organizations to respond more quickly and strategically.”
Serving Over 200 Healthcare and Life Sciences Organizations
Komodo’s comprehensive suite, which includes the MapLab platform, is currently in use by more than 200 healthcare and Life Sciences organizations. These include well-known names such as Johnson & Johnson, Merck, Novo Nordisk, MoonLake Immunotherapeutics, Regeneron, and Takeda Pharmaceuticals. These tools assist companies in evaluating strategic impacts and filling gaps in patient care, empowering them to take informed actions effectively.
Join Our Upcoming Webinar to Learn More
On October 10, Komodo Health will host a webinar that provides further insights into how MapAI and MapExplorer can improve analytics and decision-making. Participants are encouraged to register to discover how to leverage these tools for better healthcare outcomes.
About Komodo Health
Komodo Health is leading the way in technological advancements, setting a new standard for real-world data and analytics. By integrating a broad view of patient encounters with artificial intelligence, Komodo correlates individual patient journeys with large-scale health outcomes. Their platform caters to various stakeholders—including Life Sciences, payers, and providers—promoting the extraction of meaningful, patient-centric insights at scale. By merging clinical data with advanced algorithms and AI-driven tools, Komodo Health seeks to improve decision-making processes, address significant care gaps, and reduce the burden of diseases, all while creating a more efficient healthcare ecosystem. For more information about Komodo Health, you can visit their official website.
Frequently Asked Questions
What are the new tools launched by Komodo Health?
The two new tools launched by Komodo Health are MapAI and MapExplorer, designed to enhance access to patient-level insights and streamline analytics in healthcare.
How does MapAI assist users in data analysis?
MapAI is an AI analytics assistant that simplifies data analysis with natural language processing, allowing users to pose complex questions and receive answers quickly, which enhances decision-making.
How does MapExplorer benefit Life Sciences companies?
MapExplorer democratizes access to immediate insights for Life Sciences companies, enabling them to explore patient demographics and treatment pathways quickly before conducting detailed analyses.
When is the upcoming webinar about these new tools?
Komodo Health will host a webinar on October 10, offering insights on how MapAI and MapExplorer can enhance analytics and decision-making.
Which organizations are currently using Komodo’s MapLab platform?
More than 200 healthcare and Life Sciences organizations use Komodo's MapLab platform, including major companies like Johnson & Johnson, Merck, and Takeda Pharmaceuticals.
